| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PNAS..112.7719W |
| P356 | DOI | 10.1073/PNAS.1423344112 |
| P932 | PMC publication ID | 4485132 |
| P698 | PubMed publication ID | 26060313 |
| P5875 | ResearchGate publication ID | 278044612 |
| P50 | author | Julio Saez-Rodriguez | Q41044850 |
| Pedro R Cutillas | Q37837068 | ||
| P2093 | author name string | John G Gribben | |
| Camille Terfve | |||
| Edmund H Wilkes | |||
| P2860 | cites work | Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 |
| A comprehensive pathway map of epidermal growth factor receptor signaling | Q24672490 | ||
| What a tangled web we weave: emerging resistance mechanisms to inhibition of the phosphoinositide 3-kinase pathway | Q26825780 | ||
| Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo | Q27852093 | ||
| Characterization of a TiO₂ enrichment method for label-free quantitative phosphoproteomics. | Q39593373 | ||
| Activation of a non-genomic Pim-1/Bad-Pser75 module is required for an efficient pro-survival effect of Bcl-xL induced by androgen in LNCaP cells | Q39615346 | ||
| Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibition. | Q39643400 | ||
| Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. | Q53114408 | ||
| A comparison of normalization methods for high density oligonucleotide array data based on variance and bias | Q27860710 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
| Functional discovery via a compendium of expression profiles | Q27938962 | ||
| Upstream and downstream of mTOR | Q28277365 | ||
| KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
| Systematic Discovery of In Vivo Phosphorylation Networks | Q30002403 | ||
| Phosphoproteomics data classify hematological cancer cell lines according to tumor type and sensitivity to kinase inhibitors | Q30620482 | ||
| Systems analysis of EGF receptor signaling dynamics with microwestern arrays | Q33896605 | ||
| The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. | Q33928657 | ||
| Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast | Q34156122 | ||
| Untangling the wires: a strategy to trace functional interactions in signaling and gene networks | Q34190157 | ||
| Reconstruction of cellular signalling networks and analysis of their properties | Q34385115 | ||
| Control of cell survival by IGF signaling pathways. | Q34783558 | ||
| Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms | Q35204583 | ||
| Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells | Q35816378 | ||
| A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes | Q35832269 | ||
| Ecological and evolutionary dynamics of coexisting lineages during a long-term experiment with Escherichia coli | Q36066277 | ||
| Crowdsourcing network inference: the DREAM predictive signaling network challenge | Q36300033 | ||
| Network inference using informative priors | Q36936327 | ||
| Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models | Q37024819 | ||
| Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. | Q37189824 | ||
| Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) | Q37257487 | ||
| Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo. | Q37281508 | ||
| mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer | Q37605004 | ||
| Simplistic pathways or complex networks? | Q37680171 | ||
| Mass spectrometry-based proteomics and network biology | Q37996108 | ||
| Tumor adaptation and resistance to RAF inhibitors | Q38160738 | ||
| Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies | Q38249099 | ||
| The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma | Q39210830 | ||
| Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance. | Q39355884 | ||
| Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition | Q39458630 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 7719-7724 | |
| P577 | publication date | 2015-06-09 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Empirical inference of circuitry and plasticity in a kinase signaling network | |
| P478 | volume | 112 |
| Q92736101 | A Network Module for the Perseus Software for Computational Proteomics Facilitates Proteome Interaction Graph Analysis |
| Q38816181 | Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics. |
| Q92947129 | An Integrative Analysis of Tumor Proteomic and Phosphoproteomic Profiles to Examine the Relationships Between Kinase Activity and Phosphorylation |
| Q40281817 | An atlas of human kinase regulation |
| Q38660465 | Approaches to identify kinase dependencies in cancer signalling networks |
| Q31162178 | Benchmarking substrate-based kinase activity inference using phosphoproteomic data |
| Q100464024 | CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor |
| Q90207575 | Cancer associated fibroblast FAK regulates malignant cell metabolism |
| Q38665267 | Clinical implications of recent advances in proteogenomics. |
| Q37284069 | Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway |
| Q37393164 | Disulfide-activated protein kinase G Iα regulates cardiac diastolic relaxation and fine-tunes the Frank-Starling response. |
| Q38906990 | Exploiting receptor tyrosine kinase co-activation for cancer therapy |
| Q64120159 | INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases |
| Q38989188 | Impact of phosphoproteomics in the translation of kinase-targeted therapies. |
| Q37085845 | Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells |
| Q38695269 | Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability. |
| Q38668703 | Label-Free Phosphoproteomic Approach for Kinase Signaling Analysis |
| Q30992504 | Large-scale models of signal propagation in human cells derived from discovery phosphoproteomic data |
| Q90989940 | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition |
| Q59794905 | Oxidative Stress in Cells with Extra Centrosomes Drives Non-Cell-Autonomous Invasion |
| Q37716027 | Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition |
| Q53705802 | PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. |
| Q39036639 | Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate |
| Q49979433 | Phosphoproteomics-Based Profiling of Kinase Activities in Cancer Cells |
| Q49919440 | Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells |
| Q54117167 | Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells. |
| Q92784359 | Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring |
| Q58802584 | Reconstructing phosphorylation signalling networks from quantitative phosphoproteomic data |
| Q57292332 | Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis |
| Q40643093 | Stabilization of the metaphase spindle by Cdc14 is required for recombinational DNA repair. |
Search more.